Spectrum Pharmaceuticals Incorporated - symbol SPPI - reported that the FDA has granted FUSILEV (levoleucovorin) “Orphan Drug” exclusivity for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.
KOMENTAR
0